GBM subtypes are characterized by abnormalities in platelet-derived growth factor alpha (PDGFRA), isocitrate dehydrogenase1 (IDH1), epidermal growth factor receptor (EGFR), and neurofibromin1 (NF1)116. The gene discussed is NF1; the disease is glioblastoma.